Synthesis and Structure of 5-Methyl-9-(trifluoromethyl)-12H-quino[3,4-b][1,4]benzothiazinium Chloride as Anticancer Agent
Molecules · 2024
DOI: 10.3390/molecules29184337 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Andrzej Zieba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellonska 4, 41-200 Sosnowiec, Po…. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice, Poland, University of Silesian in Katowice, PBKM S.A. FamiCord Group.
Abstract (Originalsprache)
In this work, the synthesis, structural analysis and anticancer properties of 5-methyl-9-trifluoromethyl-12H-quino[3,4-b][1,4]benzothiazinium chloride (3) are described. Compound 3 was synthesized by reacting 1-methyl-4-butylthio-3-(benzoylthio)quinolinium chloride with 4-(trifluoromethyl)aniline, respectively. The structure of the resulting product was determined using 1H-NMR and 13C-NMR spectroscopy as well as HR-MS spectrometry. The spatial geometry of agent 3 and the arrangement of molecules in the crystal (unit cell) were also confirmed using X-ray diffraction. The tetracyclic quinobenzothiazinium system is fairly planar because the dihedral angle between the planes formed by the benzene ring and the quinoline system is 173.47°. In order to obtain insight into the electronic charge distribution of the investigated molecule, electronic structure calculations employing the Density Functional Theory (DFT) were performed. Moreover, antiproliferative activity against a set of pancreatic cancer cell lines was tested, with compound 3 showing IC50 values against human primary pancreatic adenocarcinoma BxPC-3 and human epithelioid pancreatic carcinoma Panc-1 of 0.051 µM and 0.066 µM, respectively. The IC50 value of cytotoxicity/cell viability of the investigated compound assessed on normal human lung fibroblasts WI38 was 0.36 µM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jagiellonska 4, 41-200 Sosnowiec, Poland.
- Institute of Chemistry, University of Silesia, Szkolna 9, 40-007 Katowice, Poland.
- Faculty of Mathematics and Natural Sciences, Cardinal Stefan Wyszynski University, K. Woycickiego 1/3, 01-938 Warszawa, Poland.
- Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, ul. Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland.
ORCID-Profile: Andrzej Zieba, Kinga Suwinska, Agata Kawulok, Tadeusz Pluta, Josef Jampilek, Andrzej Bak
Förderung
- Medical University of Silesia in Katowice, Poland
- University of Silesian in Katowice
- PBKM S.A. FamiCord Group
Zitieren
APA
Zieba, A., Kozik, V., Suwinska, K., Kawulok, A., Pluta, T., Jampilek, J., & Bak, A. (2024). Synthesis and Structure of 5-Methyl-9-(trifluoromethyl)-12H-quino[3,4-b][1,4]benzothiazinium Chloride as Anticancer Agent. Molecules. https://doi.org/10.3390/molecules29184337
Vancouver
Zieba A, Kozik V, Suwinska K, Kawulok A, Pluta T, Jampilek J, et al. Synthesis and Structure of 5-Methyl-9-(trifluoromethyl)-12H-quino[3,4-b][1,4]benzothiazinium Chloride as Anticancer Agent. Molecules. 2024. doi:10.3390/molecules29184337
BibTeX
@article{Zieba2024,
author = {Zieba, Andrzej and Kozik, Violetta and Suwinska, Kinga and Kawulok, Agata and Pluta, Tadeusz and Jampilek, Josef and Bak, Andrzej},
title = {Synthesis and Structure of 5-Methyl-9-(trifluoromethyl)-12H-quino[3,4-b][1,4]benzothiazinium Chloride as Anticancer Agent},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29184337}
}
EUVIMED